Contact this trialFirst, we need to learn more about you.
Platinum-containing Compound
TRC102 + Chemotherapy/Radiation for Lung Cancer
Recruiting1 awardPhase 2
New Brunswick, New Jersey
This trial is testing whether adding TRC102 to the usual care treatment of pemetrexed, cisplatin, and radiation therapy followed by durvalumab works better than the usual care treatment alone in patients with stage III non-squamous non-small cell lung cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service